Literature DB >> 2809911

Nephropathic cystinosis: improved linear growth after treatment with recombinant human growth hormone.

D P Wilson1, D Jelley, R Stratton, J G Coldwell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2809911     DOI： 10.1016/s0022-3476(89)80658-4

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  4 in total

Review 1.  Disturbance of growth hormone--insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment.

Authors:  B Tönshoff; F Schaefer; O Mehls
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

2.  Growth hormone treatment in children with preterminal chronic renal failure: no adverse effect on glomerular filtration rate.

Authors:  B Tönshoff; C Tönshoff; O Mehls; J Pinkowski; W F Blum; U Heinrich; B Stöver; N Gretz
Journal:  Eur J Pediatr       Date:  1992-08       Impact factor: 3.183

3.  Recombinant human growth hormone treatment of children with chronic renal failure: long-term (1- to 3-year) outcome.

Authors:  R N Fine; K Pyke-Grimm; P A Nelson; M I Boechat; B M Lippe; O Yadin; E Kamil
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

4.  The Effects of 20-kDa Human Placental GH in Male and Female GH-deficient Mice: An Improved Human GH?

Authors:  Edward O List; Darlene E Berryman; Reetobrata Basu; Mathew Buchman; Kevin Funk; Prateek Kulkarni; Silvana Duran-Ortiz; Yanrong Qian; Elizabeth A Jensen; Jonathan A Young; Gozde Yildirim; Shoshana Yakar; John J Kopchick
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.